Xylocaine Injection, Solution
Product Images NDC 51662-1591

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 51662-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1590 Case (1590 Case 1)

XYLOCAINE (Lidocaine HCl Injection) 20 mg/mL solution for injection, 50 mL vial, packaged by HF Acquisition Co LLC, DBA HealthFirst. The label indicates a box containing 25 vials. It includes usage instructions for infiltration and nerve block, storage conditions, and manufacturer information based in Mukilteo, WA.*

FDA Label Image

1590 Pouch (1590 Pouch 1)

XYLOCAINE (Lidocaine HCl) Injection, USP 2% 1000 mg/50 mL (20 mg/mL) 50 mL vial. The label indicates it is for infiltration and nerve block use, not for caudal or epidural use. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. The vial is single-use and sterile with storage instructions at 20°C to 25°C (68°F to 77°F).*

FDA Label Image

1590 Rfid (1590 Rfid 1)

XYLOCAINE injection solution vial label showing product identification codes including batch number, expiration date, and distributor information. Label indicates distribution by HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA 98275. The vial label is primarily white with black text and includes numeric codes relevant to product tracking.*

FDA Label Image

1590 Vial (1590 Vial 1)

XYLOCAINE 2% (lidocaine HCl Injection, USP) 1000 mg per 50 mL (20 mg per mL) injection solution for infiltration and nerve block. The label indicates 50 mL multiple dose vial, not for caudal or epidural use. Manufactured by Fresenius Kabi, with storage instructions and sterility information.*

FDA Label Image

1591 Case (1591 Case 1)

XYLOCAINE (Lidocaine HCl) Injection, USP 1% 200 mg/20 mL (10 mg/mL) 20 mL vial, package of 25. The label includes lot number, expiration date, and handling instructions specifying it is for infiltration and nerve block, not for caudal or epidural use. The manufacturer is HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. The label also notes that the solution should be clear and colorless, with preservatives and storage conditions detailed.*

FDA Label Image

1591 Pouch (1591 Pouch 1)

XYLOCAINE (Lidocaine HCl Injection, USP) 1% 20 mg/mL solution for injection in a 20 mL vial. The label includes NDC 51662-1591-2, lot number, expiration date, and manufacturer information by HF Acquisition Co LLC, Mukilteo, WA. The label cautions sterile, nonpyrogenic use and storage at controlled room temperature (68°F to 77°F).*

FDA Label Image

1591 Rfid (1591 Rfid 1)

The image shows a label with barcode and batch information related to the XYLOCAINE injection solution. It includes identifiers such as GTIN codes, lot number, and a reference to the manufacturer, HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. No strength or dosage form text is visible in this section.*

FDA Label Image

1591 Vial (1591 Vial 1)

XYLOCAINE 1% injection, solution with 10 mg/mL lidocaine HCl, presented as 20 mL multiple dose vial. The label states the product is for infiltration and nerve block, not for caudal or epidural use. It is sterile, nonpyrogenic, and can be resterilized by autoclaving. Storage instructions specify 20° to 25°C. Labeled by Fresenius Kabi, Lake Zurich, IL.*

FDA Label Image

Logo (Logo)

FDA Label Image

Max Dose (Max Dose)

A data table listing various medical procedures alongside corresponding doses (percent and milliliters) and total dose in milligrams for Xylocaine injection solution. The table includes procedures like infiltration, perineural blocks, thoracic, lumbar, cervical nerve blocks, and others, showing dosage variations for the product strengths 10 mg/mL and 20 mg/mL.*

FDA Label Image

P1 (Precautions)

A data table listing drug classes and examples of drugs in each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with specific drug names provided under each category.*

FDA Label Image

S1 (Structure 1)

Chemical structure diagram of the active ingredient in XYLOCAINE injection, solution, showing the molecular components and arrangement including aromatic ring and ethyl groups, with HCl indicated.*

FDA Label Image

S2 (Structure 2)

Chemical structure diagram depicting the molecular composition of the active ingredient in XYLOCAINE injection solution. The structure shows a benzene ring with hydroxyl groups and an attached side chain indicating the molecular arrangement of the drug component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.